PharmaBoardroom

Beh Kian Teik of Singapore’s National Research Foundation (NRF) outlines the importance of the life sciences within the country’s innovation…

EY’s Abhay Bangi highlights the key trends across the ASEAN life sciences space, how the COVID-19 pandemic has accelerated them, and charts…

Innovation is at the heart of healthcare transformation and the doors for a much-needed shift from provider- to patient-centric solutions have been…

TITCK is the regulatory agency in charge of ensuring the safety of medicines, health products, cosmetics, and personal care products in Turkey. Its…

A historic approval for Fosun-Kite’s CAR-T therapy Yescarta in China looks set to pave the way for further developments in the Chinese cell and gene…

During a year where the Mexican economy shrank 8.5 percent, Novartis Mexico experienced a modest one percent growth which Country President Fernando…

The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced…

After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and…

The Top 10 pharma companies in Ireland, ranked by annual turnover in The Irish Times Top 1000 list for 2021. Dublin-headquartered Allergan tops the…

Dr Fayad Al Dandashi, CEO of Tamer HealthCare, a leading Saudi healthcare company, discusses how the group aims to benefit from Saudi Arabia’s…

Simranjit Singh highlights Guardant Health’s role in the global precision oncology landscape and how the company leverages its proprietary blood…

Hussein El Hakim, managing director for Bayer Saudi Arabia and general manager for its pharmaceuticals division in the country, discusses the…